Recent work | January 26, 2022

Roschier represented Nordstjernan in its investment in medtech company Ascilion

Swedish investment company Nordstjernan has invested in Swedish medtech company Ascilion, an investment that makes Nordstjernan the second largest owner in Ascilion. Roschier acted for Nordstjernan in the transaction.

Ascilion was founded in 2012 and has developed and patented a technology that can improve current diagnostics methods within several branches of medical diagnostics.

Roschier’s main advisory team comprised Markus Olsson, Erik Ficks, John Park, Mathilda Hoffman, Susanne Mellqvist and Elias Olsson.